Related Experiment Video

Updated: Aug 7, 2026

Optimizing Tubulin Yield from Porcine Brain Tissue
06:30

Optimizing Tubulin Yield from Porcine Brain Tissue

Published on: October 11, 2024

The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics

Matteo Magnani1, Francesco Ortuso, Simonetta Soro

  • 1Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Italy.

The FEBS Journal
|June 29, 2006
PubMed

Insights

Anticancer drugs paclitaxel and IDN5390 target beta-tubulin. Computational analysis reveals their binding modes, explaining resistance mechanisms and guiding the development of novel antimitotic agents.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Computational Chemistry

Background:

  • Microtubule-targeting agents are crucial in cancer therapy.
  • Paclitaxel is effective against ovarian, breast, and lung cancers.
  • Resistance to paclitaxel is linked to increased betaIII-tubulin, with IDN5390 effective against resistant cancers.

Purpose of the Study:

  • To analyze the binding modes of paclitaxel, IDN5390, and epothilone A to beta-tubulin isoforms I and III using computational methods.
  • To provide a molecular explanation for observed experimental data regarding drug resistance.
  • To offer insights for designing improved antimitotic agents.

Main Methods:

  • Computational analysis of binding modes.
  • Molecular modeling of antimitotic agents interacting with beta-tubulin isoforms.
  • Comparative analysis of drug-target interactions.

Main Results:

  • The study provides a molecular basis for paclitaxel and IDN5390 binding to beta-tubulin isoforms.
  • It explains the emergence of resistance related to betaIII-tubulin abundance.
  • Epothilone A showed no isoform preference, suggesting a different resistance profile.

Conclusions:

  • The findings offer structural insights into the recognition and stabilization mechanisms of antimitotic drugs.
  • This research aids in understanding drug resistance in cancer therapy.
  • The study provides a foundation for the rational design of more effective and selective anticancer drugs.

More Related Videos

Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles07:54

Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles

Published on: November 5, 2020

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation of...
Microtubules01:18

Microtubules

Microtubules are the thickest cytoskeletal filaments with a diameter of 25 nm. In prokaryotic organisms, microtubules are commonly found in locomotory appendages like cilia and flagella. In eukaryotic cells, microtubules form specialized extensions for moving fluid over the surface, like those found in cells lining the intestine.
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer. These αβ-heterodimers...